Medical device licence · 12591 · Class 3
LCX PROBE SYSTEM
No longer licensed: discontinued at renewal
Licence status Discontinued at renewal; first licensed September 27, 1999; ended November 5, 2007. It is in Health Canada’s archive of licences no longer in force.
- Licence number
- 12591
- Licence holder
- Abbott Laboratories Diagnostics DivisionAbbott Park, IL, United States
- Risk class
- Class III (moderate to high risk)
- Licence type
- System
- First licensed
- September 27, 1999
- Ended
- November 5, 2007
- Devices covered
- 5
Devices on this licence
By name, as listed. The official record lists model numbers and identifiers.
- LCX PROBE SYSTEM (MYCOBACTERIUM TUBE- RCULOSIS ASSAY)(AMPL. & DETECTION KIT
- LCX PROBE SYSTEM ANALYZER - CLASS 3
- LCX PROBE SYSTEM CHLAMYDIA
- LCX PROBE SYSTEM HIV RNA QUANTITATIVE ASSAY
- LCX PROBE SYSTEM NEISSERIA GONORRHEA ASSAY (AMPLIFICATION)
Class I devices, the lowest-risk group, mostly need no device licence, so most are not in this list.